Status:
COMPLETED
Using Mobile Technology to Enhance Early Psychosis Treatment Delivery
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
Ginger.io
Conditions:
Psychosis
Clinical High Risk for Psychosis
Eligibility:
All Genders
13-30 years
Phase:
NA
Brief Summary
This project tests the feasibility of implementing a smartphone application - Ginger.io - in the UC Davis Early Psychosis Program, and investigates whether mobile health technology can improve treatme...
Detailed Description
The project comprises two phases. In both phases, patients will use the Ginger.io app on their mobile device to complete daily surveys assessing mood and social interactions, and weekly surveys assess...
Eligibility Criteria
Inclusion
- Ages 13-30, English fluency
Exclusion
- IQ Below 70, history of neurological disorders, or current substance abuse/dependence.
Key Trial Info
Start Date :
December 14 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT03303456
Start Date
December 14 2014
End Date
November 1 2015
Last Update
October 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Imaging Research Center
Sacramento, California, United States, 95817